U.S. Markets open in 42 hrs, 54 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 18.01 09:39 AM EDT | |
|---|---|---|
| Day High | 18.73 11:00 AM EDT |
|
| Range | 0.72 |
| Volume | 104,896 | |
|---|---|---|
| 30-Day Avg Vol | 46,000 |
|
| Difference | 128.03% |
| Market Cap | 344.42 M | |
|---|---|---|
| Mkt Cap Chg | -9.61 M |
| Shares Out | 18.86 M | |
|---|---|---|
| % Shrs Traded | 0.56% | |
| 1yr EPS Est | -5.362 |
| 52-Wk Low | 8.52 12/22/08 | |
|---|---|---|
| 52-Wk High | 22.6199 8/12/08 |
|
| Range | 14.10 |
| Prev Close | 18.77 7/1/09 | |
|---|---|---|
| Today's Open | 18.45 | |
| Change | -1.70% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 341,302.00 |
| Revenue (LFY) | 82.85 M | |
|---|---|---|
| Earnings (LFY) | -86.51 M | |
| Earnings (MRQ) | -21.74 M | |
| Next Earn Est | -1.266 | |
| Next Earnings | 08/17/2009 |
|
| EPS (TTM) | -5.97 | |
| 1yr EPS Growth | 10.18% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | -184.67 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Affymax is designing peptides to give red blood cells a pep talk. The biotechnology firm is researching and developing possible drugs based upon these biological process regulators. Its leading drug candidate ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -1.266 8/17/09 | — — |
—
—
|
| Last Quarter | -1.482 3/31/09 | -1.32 3/31/09 |
0.162
Beat
|
| 2 Quarters Ago | -1.465 12/31/08 | -1.69 12/31/08 |
-0.225
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 25.85 M | 82.85 M |
| Gross Profit | 25.40 M | 81.56 M |
| Operating Income | -22.01 M | -88.73 M |
| Net Income | -21.74 M | -86.51 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts